Modern approaches to cancer prevention: Universal or personal?

• Personalized medicine is a response to emerging technologies and commercialization.
• Testing for high risk genes will not impact on global cancer rates.
• Testing for low risk genes has little promise for preventing cancer.
• The impact of new technologies should be evaluated from a population perspective.
• Genetic tests will have most potential for impact if made available to all.